Research Hub — Stem Cell & PRP Science

The Native Stem Cell Research Hub is your trusted source for clinical evidence, scientific literature, and educational articles related to regenerative orthopedics.

Our goal is to make complex medical research accessible and understandable for patients, journalists, and healthcare professionals.

What You’ll Find in Our Research Hub

Clinical Studies & Evidence Summaries

We compile peer-reviewed research on:

  • Bone marrow–derived stem cell therapy

  • PRP effectiveness for arthritis and tendon injuries

  • Orthobiologics in sports medicine

  • Cartilage and soft-tissue healing

Clinical studies related to regenerative orthopedics

  • Summaries of research on PRP, stem cells, orthobiologics
  • Articles explaining how biologic treatments work
  • Treatment science behind ReVivaStem®
  • Ongoing updates to keep patients informed

Educational Articles

Plain-language explanations of:

  • Regenerative healing mechanisms

  • How PRP and stem cells work

  • Differences between treatment types

  • The role of imaging in precision injection

  • What research says about outcomes

ReVivaStem® Scientific Foundation

Insights into how our proprietary stem cell protocol aligns with:

  • Orthopedic biology

  • Minimally manipulated cell standards

  • Biomechanical joint support

  • Natural healing pathways

Leading Topics in Regenerative Medicine

Explore Articles, Studies & Guides

BMAC for Grade 3–4 Knee Osteoarthritis (Heliyon, 2018)

Retrospective cohort (n=233) reporting improvements in pain and function after a single intra-articular BMAC injection.

Bone Marrow Concentrate for Hip OA (Registry Results)

Prospective registry describing pain and Oxford Hip Score changes and reported safety after BMC for hip osteoarthritis.

HA-BMAC vs Microfracture (5-Year Cartilage Repair)

Comparative cohort showing durability of function scores with HA scaffold + BMAC versus microfracture for knee cartilage lesions.

Allogeneic BM-MSC for Knee OA (Randomized Trial)

RCT comparing allogeneic BM-MSC to hyaluronic acid with clinical and MRI T2-mapping outcomes at 12 months.

Orthopedic Applications of Stem Cell Therapy — Policy

BCBS policy overview and FDA HCT/P considerations (21 CFR 1271) related to orthobiologics in orthopedic care.

Our Commitment to Evidence-Based Care

Native Stem Cell Clinics strictly follow:

We only recommend regenerative therapy when appropriate.

If you’re looking for a natural, non-surgical way to reduce pain and heal your joints, Native Stem Cell is here to help. Schedule your consultation today and discover the regenerative options available to you.